Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zhengye Biotechnology Holding (ZYBT) Total Liabilities (2023 - 2025)

Zhengye Biotechnology Holding has reported Total Liabilities over the past 3 years, most recently at $18.3 million for Q4 2025.

  • Quarterly Total Liabilities fell 6.61% to $18.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $18.3 million through Dec 2025, down 6.61% year-over-year, with the annual reading at $18.6 million for FY2025, 3.72% down from the prior year.
  • Total Liabilities was $18.3 million for Q4 2025 at Zhengye Biotechnology Holding, down from $19.5 million in the prior quarter.
  • Over five years, Total Liabilities peaked at $22.3 million in Q4 2023 and troughed at $18.3 million in Q4 2025.
  • The 3-year median for Total Liabilities is $19.5 million (2024), against an average of $19.9 million.
  • Year-over-year, Total Liabilities decreased 12.19% in 2024 and then decreased 6.61% in 2025.
  • A 3-year view of Total Liabilities shows it stood at $22.3 million in 2023, then decreased by 12.19% to $19.6 million in 2024, then fell by 6.61% to $18.3 million in 2025.
  • Per Business Quant, the three most recent readings for ZYBT's Total Liabilities are $18.3 million (Q4 2025), $19.5 million (Q2 2025), and $19.6 million (Q4 2024).